Advertisement

Response to Letter to the Editor Regarding “A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis”

  • Sheila RidnerEmail author
  • Frank Vicini
  • Mary S. Dietrich
  • Chirag Shah
Breast Oncology
  • 17 Downloads

To the Editors:

We thank Dr. Barrio and colleagues for their letter which allows for further discussion of breast cancer-related lymphedema (BCRL) and the interim findings from the PREVENT trial.

We agree that there is a need for widespread adoption of BCRL screening (including baseline and follow-up screening) and to identify strategies that allow for BCRL screening in a variety of clinical environments. This was and remains a goal of the PREVENT study, to show that prospective surveillance, coupled with early intervention, reduces rates of chronic BCRL and the need for costly and time-consuming treatments such as complex decongestive physiotherapy (CDP).

It was understood during the design of the PREVENT study that the screening technique utilized would not be expected to change BCRL diagnosis rates. Rather, the hypothesis was that a more sensitive diagnostic technique might allow for detection at an earlier phase of the disease and reduce rates of chronic BCRL. The team decided to...

Notes

Disclosure

Chirag Shah is scientific consultant for ImpediMed Limited. Frank Vicini is scientific consultant and chief medical officer for ImpediMed Limited.

References

  1. 1.
    Oremus M, et al. Diagnosis and treatment of secondary lymphedema. Hamilton: McMaster University Evidence-based Practice Center; 2010.Google Scholar
  2. 2.
    Cornish BH, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34(1):2–11.Google Scholar
  3. 3.
    Wasserstein RL, et al. Moving to a world beyond “p < 0.05”. Am Stat. 2019;73(1):1–19.CrossRefGoogle Scholar
  4. 4.
    Kyriacou DN. The enduring evolution of the P value editorial. JAMA. 2016;315(11):1113–5.CrossRefGoogle Scholar
  5. 5.
    Kilgore LJ, et al. Reducing breast cancer-related lymphedema (BCRL) through prospective surveillance monitoring using bioimpedance spectroscopy (BIS) and patient directed self-interventions. Ann Surg Oncol. 2018;25(10):2918–52.CrossRefGoogle Scholar
  6. 6.
    Soran A, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol. 2014;12(4):289–94.CrossRefGoogle Scholar
  7. 7.
    Lawenda BD, et al. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59(1):8–24.CrossRefGoogle Scholar
  8. 8.
    NCCN. NCCN clinical practice guidelines in oncology (NCCN guidelines®) for breast cancer V.2.2017. Fort Washington: NCCN; 2017.Google Scholar
  9. 9.
    ACI. Lymphoedema: a guide for clinical services. Chatswood: NSW Agency for Clinical Innovation; 2018.Google Scholar
  10. 10.
    Stout Gergich L, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809–19.CrossRefGoogle Scholar
  11. 11.
    Vicini F, et al. Bioelectrical impedance for detecting and monitoring patients for the development of upper limb lymphedema in the clinic. Clin Breast Cancer. 2012;12(2):133–7.CrossRefGoogle Scholar
  12. 12.
    Shah C, et al. The use of bioimpedance spectroscopy to monitor therapeutic intervention in patients treated for breast cancer related lymphedema. Lymphology. 2013;46(4):184–92.Google Scholar
  13. 13.
    Reichart K. Lymphedema: improving screening and treatment among at-risk breast cancer survivors. Clin J Oncol Nurs. 2017;21(1):21–5.CrossRefGoogle Scholar
  14. 14.
    Barney L and Savarise MT. 2015 CPT coding changes will have mixed effects on payment for general surgeons. Bull Am Coll Surg. 2015;100(1):17–26.Google Scholar
  15. 15.
    Koelmeyer LA, et al. Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care. Cancer. 2018;125(6):854–62.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Sheila Ridner
    • 1
    Email author
  • Frank Vicini
    • 2
  • Mary S. Dietrich
    • 3
  • Chirag Shah
    • 4
  1. 1.School of NursingVanderbilt UniversityNashvilleUSA
  2. 2.21st Century Oncology, Michigan Healthcare ProfessionalsFarmington HillsUSA
  3. 3.Vanderbilt UniversityNashvilleUSA
  4. 4.Cleveland Clinic, Radiation OncologyClevelandUSA

Personalised recommendations